Assessment of BI-RADS reliability in sonomammographic diagnosis of breast Masses confirmed by postoperative histopathology: A multicenter observational study | ||||
| ARCADEs of MEDICINE | ||||
| Articles in Press, Accepted Manuscript, Available Online from 26 May 2025 | ||||
| Document Type: Original Research | ||||
| DOI: 10.21608/arcmed.2025.387688.1129 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Hazem Gamal Ghanem  1; Ibrahim Abdelrafeh2; Mohammad Ibrahim Moneir2; Mohamed Abobakr Elseddik3
| ||||
| 1General surgery department Armed Forces college of medicine | ||||
| 2General surgery department Armed forces college of medicine | ||||
| 3Radiodiagnosis department, Armed forces college of Medicine, Cairo, Egypt | ||||
| Abstract | ||||
| Background The typical manifestation of both benign and malignant tumours is a breast lump, and triple assessment increases the accuracy of the diagnosis. BI-RADS based on sonomammography provides malignancy risk classification and standardized reporting. Its diagnostic accuracy in determining breast masses is assessed in this study. Methods: This observational analysis included 77 surgical patients with breast masses who had their diagnoses confirmed by histopathology after undergoing sonomammography and BI-RADS scoring in accordance with ACR standards. Although limited by selection bias, the inclusion of surgical cases ensured diagnostic accuracy, supporting the BI-RADS-malignancy correlation in a high-risk population. Results: The distribution of BI-RADS among the benign lesions was as follows: one lesion was categorised as BI-RADS 5, twelve as BI-RADS 4b, three as BI-RADS 4c, eight cases as BI-RADS 3, and fourteen as BI-RADS 4a. No cases were identified as BI-RADS 3 among the malignant lesions; two were identified as BI-RADS 4a, three as BI-RADS 4b, eleven as BI-RADS 4c, and twenty-three as BI-RADS 5. Higher BI-RADS categories were positively correlated with a higher risk of malignancy, as evidenced by the following data: 0% in BI-RADS 3, 12.5% in 4a (2/16), 20% in 4b (3/15), 78.6% in 4c (11/14), and 95.8% in BI-RADS 5 (23/24). The diagnostic performance metrics addressed in discussion . Conclusion: Although the results should be interpreted cautiously due to the limited sample size and potential interobserver variability, this study supports the relevance of higher BI-RADS categories in surgical decision-making by confirming a robust association between them and malignancy. | ||||
| Keywords | ||||
| BI-RADS; Postoperative-histopathology; Breast cancer | ||||
|
Statistics Article View: 53 |
||||
